genedrive plc
genedrive plc engages in the design, development, and manufacture of molecular diagnostics testing equipment for use in genotyping, pathogen detection, infectious disease detection, and other clinical indications. The company provides Genedrive system, rapid nucleic acid thermocycler and fluorescence signal detection system for target discrimination used for qualitative in vitro molecular diagnos… Read more
genedrive plc (GDR) - Total Assets
Latest total assets as of June 2025: GBX2.81 Million GBX
Based on the latest financial reports, genedrive plc (GDR) holds total assets worth GBX2.81 Million GBX as of June 2025.
Total assets represent everything the company owns and controls, combining both current assets—like cash and cash equivalents, accounts receivable, and inventories—and non-current assets such as property, plant, equipment (PP&E), intangible assets, and long-term investments.
genedrive plc - Total Assets Trend (2006–2025)
This chart illustrates how genedrive plc’s total assets have evolved over time, based on quarterly financial data. Explore and compare other companies by total assets.
genedrive plc - Asset Composition Analysis
Current Asset Composition (June 2025)
genedrive plc's total assets of GBX2.81 Million consist of 95.4% current assets and 4.6% non-current assets.
| Asset Category | Amount (GBX) | % of Total Assets |
|---|---|---|
| Cash & Equivalents | GBX0.00 | 42.0% |
| Accounts Receivable | GBX1.07 Million | 38.2% |
| Inventory | GBX428.00K | 15.2% |
| Property, Plant & Equipment | GBX0.00 | 0.0% |
| Intangible Assets | GBX0.00 | 0.0% |
| Goodwill | GBX0.00 | 0.0% |
Asset Composition Trend (2006–2025)
This chart illustrates how genedrive plc's asset composition has evolved over time. Understanding changes in asset allocation can provide insights into the company's strategic shifts, capital allocation priorities, and business focus evolution.
Key Asset Composition Facts
- Current vs. Non-Current Assets: genedrive plc's current assets represent 95.4% of total assets in 2025, an increase from 76.2% in 2006.
- Cash Position: Cash and equivalents constituted 42.0% of total assets in 2025, down from 45.7% in 2006.
- Tangible vs. Intangible: Intangible assets (including goodwill) make up 0.0% of total assets, a decrease from 4.0% in 2006.
- Asset Diversification: The largest asset category is accounts receivable at 38.2% of total assets.
genedrive plc Competitors by Total Assets
Key competitors of genedrive plc based on total assets are shown below.
| Company | Country | Total Assets |
|---|---|---|
|
ADCNF
OTCGREY:ADCNF
|
USA | $4.51 Billion |
|
Berry Genomics Co Ltd
SHE:000710
|
China | CN¥2.34 Billion |
|
Malaysian Genomics Resource
KLSE:0155
|
Malaysia | RM20.70 Million |
|
NSN Co. Ltd
KQ:031860
|
Korea | ₩60.96 Billion |
|
JOONGANG DNM Co.Ltd
KQ:051980
|
Korea | ₩121.79 Billion |
|
GeneMatrix Inc
KQ:109820
|
Korea | ₩28.03 Billion |
|
Genoray Co. Ltd
KQ:122310
|
Korea | ₩125.67 Billion |
|
Green Cross Lab Cell Corporation
KQ:144510
|
Korea | ₩565.79 Billion |
genedrive plc - Asset Efficiency Metrics
Asset efficiency metrics measure how effectively a company uses its assets to generate revenue and profits. These indicators help investors evaluate management's ability to deploy capital efficiently.
Asset Turnover Ratio
Measures how efficiently a company uses its assets to generate sales
Lower asset utilization - genedrive plc generates 0.27x its asset value in annual revenue.
Return on Assets (ROA)
Measures how efficiently a company uses its assets to generate profits
Negative ROA - genedrive plc is currently not profitable relative to its asset base.
genedrive plc - Liquidity and Working Capital Analysis
Liquidity ratios measure a company's ability to pay off its short-term debts as they come due, using the company's current or quick assets. Working capital represents the operational liquidity available.
Key Liquidity Metrics
| Metric | Current | 1 Year Ago | 5 Years Ago |
|---|---|---|---|
| Current Ratio | 1.95 | 4.60 | 4.67 |
| Quick Ratio | 1.64 | 4.33 | 4.48 |
| Cash Ratio | 0.00 | 0.00 | 0.00 |
| Working Capital | GBX1.31 Million | GBX 5.18 Million | GBX 8.06 Million |
genedrive plc - Advanced Valuation Insights
This section examines the relationship between genedrive plc's asset base and its market valuation, helping to identify whether the company's assets are efficiently translated into market value.
Key Valuation Metrics
| Current Price-to-Book Ratio | 6.80 |
| Latest Market Cap to Assets Ratio | 0.00 |
| Asset Growth Rate (YoY) | -58.6% |
| Total Assets | GBX2.81 Million |
| Market Capitalization | $1.10K USD |
Valuation Analysis
Below Book Valuation: The market values genedrive plc's assets below their book value (0.00 x), which may indicate investor concerns about asset quality or future growth.
Significant Asset Reduction: genedrive plc's assets decreased by 58.6% over the past year, potentially indicating divestiture, restructuring, or challenging business conditions.
Annual Total Assets for genedrive plc (2006–2025)
The table below shows the annual total assets of genedrive plc from 2006 to 2025.
| Year | Total Assets | Change |
|---|---|---|
| 2025-06-30 | GBX2.81 Million | -58.60% |
| 2024-06-30 | GBX6.80 Million | +50.88% |
| 2023-06-30 | GBX4.51 Million | -31.93% |
| 2022-06-30 | GBX6.62 Million | +35.76% |
| 2021-06-30 | GBX4.88 Million | -53.34% |
| 2020-06-30 | GBX10.45 Million | +44.04% |
| 2019-06-30 | GBX7.26 Million | +22.83% |
| 2018-06-30 | GBX5.91 Million | -50.95% |
| 2017-06-30 | GBX12.05 Million | +1.60% |
| 2016-06-30 | GBX11.86 Million | -25.87% |
| 2015-06-30 | GBX15.99 Million | +9.42% |
| 2014-06-30 | GBX14.62 Million | +3.87% |
| 2013-06-30 | GBX14.07 Million | +34.44% |
| 2012-06-30 | GBX10.47 Million | +34.04% |
| 2011-06-30 | GBX7.81 Million | -0.03% |
| 2010-06-30 | GBX7.81 Million | +32.03% |
| 2009-06-30 | GBX5.92 Million | +87.10% |
| 2008-06-30 | GBX3.16 Million | -5.30% |
| 2007-06-30 | GBX3.34 Million | +124.24% |
| 2006-06-30 | GBX1.49 Million | -- |